[Intrauterine pressure and fetal and maternal heart rate on administration of the betamimetic agent, hexoprenaline during labour (author's transl)].
The tocolytic effect of hexoprenaline was determined in 20 women by internal cardiotocography during labour. After 30 minutes of intravenous medication (0.3 microgram/min = dosage for massive tocolysis) the uterine activity decreased on average by 73.6%; the maternal pulse rate increased by 25.0%; the fetal heart rate showed no significant change.
D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D005318:Fetal Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects*; D006594:Hexoprenaline / Q000627:therapeutic use*; D006801:Humans; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D010627:Phenethylamines / Q000627:therapeutic use*; D011247:Pregnancy; D014590:Uterine Contraction / Q000187:drug effects*
D010627:Phenethylamines; D006594:Hexoprenaline
Intrauterine Druckverhältnisse sowie fötale und maternelle Herzfrequenz bei Applikation des Betamimetikums Hexoprenalin unter der Geburt.